SMITHFIELD, R.I.
Dow Chemical Co., based in Midland, Mich., is planning to transform a 55,000-sf facility previously occupied by Collaborative Group Ltd.’s Biotechnology Services Division into a large-molecule drugs contract manufacturing plant to serve the biotech industry. The facility will have a 50,000-liter capacity. World-wide, the capacity to produce large-molecule drugs stands at about 380,000 liters, with a critical shortage of capacity anticipated by 2005.
